In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extrac3t (EGb 761)

Mechanisms of Ageing and Development

Volumn 113, Issue 3, 2000, Pages 157-168

  Pardon, Marie Christine ^a   Joubert, Chantal ^a   Perez Diaz, Fernando ^a   Christen, Yves ^c   Launay, Jean Marie ^b   Cohen Salmon, Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c IPSEN   (France)

Author keywords

Ageing; Gingko biloba; MAO activity; Oxidation; Stress

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BIOGENIC AMINE; BRAIN MONOAMINE; GINKGO BILOBA EXTRACT;

AGING; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN MITOCHONDRION; COGNITION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; LONG TERM CARE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; STRESS;

AGING; ANIMALS; BRAIN; FEMALE; FLAVONOIDS; GINKGO BILOBA; MICE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PLANT EXTRACTS; PLANTS, MEDICINAL; STRESS;

ANIMALIA; GINGKO BILOBA; GINKGO BILOBA; GYMNOMYZA SAMOENSIS;

EID: 0033955997     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(99)00107-4     Document Type: Article

References (36)

1. Barkats M., Venault P., Christen Y., Cohen-Salmon C. Effects of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life Sci. 56:1995;213-222.
2. Chatterjee S.S. Effects of Ginkgo biloba extract on cerebral metabolic process. Agnoli A. et al. Effects of Ginkgo biloba on Organic Cerebral Impairment. 1985;5-14 John Libey, London.
3. De Feudis F.V. Ginkgo biloba extract (EGb 761): from Chemistry to the Clinic. 1998;Ullstein Medical, Wiesbaden.
4. Dursun S.M., Whitaker R.P., Andrews H., Reveley M.A. Effects of natural ageing on plasma 5-HT turn-over in humans. Hum. Psychopharmacol. Clin. Exp. 12:1997;365-367.
5. Finch C.E. Catecholamine metabolism in the brains of ageing male mice. Brain Res. 52:1973;261-276.
6. Fowler C.J., Wiberg A., Oreland L., Marcusson J., Winblad B. The effect of age on the activity and molecular properties of human brain monoamine oxydase. J. Neural. Transm. 49:1980;1-20.
7. Ingram D.K., Wiener H.L., Chachich M.E., Long J.M., Hengemihle J., Gupta M. Chronic treatment of aged mice with L-Deprenyl produces marked striatal MAOB inhibition but no beneficial effects on survival, motor performance or nigral lipofuscin accumulation. Neurobiol. Aging. 14:1993;431-440.
8. Knoll J. Selective inhibition of B type monoamine oxydase in the brain. A drug strategy to improve the quality of life in senescence. Keverling-Buisman J.A. Strategy of Drug Research. 1982;107-135 Elsevier, Amsterdam.
9. Moreau J.-L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry. 26:1993;30-33.
10. Moreau J.-L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Antidepressant treatment prevents chronic mild stress induced-anhedonia as assessed by ventral tegmentum self stimulation behaviour in rats. Eur. Neuropsychopharmacol. 2:1992;43-49.
11. Papp M., Moryl E., Willner P. Pharmacological validation of the chronic mild stress model of depression. Eur. J. Pharmacol. 296:1996;129-136.
12. Pardon M.C., Lepicard E., Perez-Diaz F., Christen Y., Cohen-Salmon C. Chronic mild stress-induced dysregulation of decision-making in mice: regulatory effect of long-term treatment with Ginkgo biloba extract (EGb 761). Papadopoulos V. et al. Adaptive Effects of Ginkgo biloba Extracts (EGb 761). 1997;Elsevier, Paris. Advances in Ginkgo biloba Extract Research Vol. 6 pp.89-98 89-98.
13. Pardon M.-C., Barkats M., Venault P., Christen Y., Cohen-Salmon C. Effect of long-term treatment with Ginkgo biloba extract (EGb 761) on age dependent structural change in the hippocampus and spatial memory performance of inbred mice. In: Christen, Y., et al. (Eds.), Effects of Ginkgo biloba extract (EGb 761) on Neuronal Plasticity, Elsevier, Paris. Advances in Ginkgo biloba Extract Research. 5:1996;21-34.
14. Piccinin G.L., Finali G., Piccirilli M. Neuropsychological effects of L-deprenyl in Alzheimer's type dementia. Clin. Neurpharmacol. 13:1990;147-163.
15. Ponzio F., Calderini G., Lomuscio G., Vantini G., Toffano G., Algeri S. Changes in monoamines and their metabolise levels in some brain regions of aged rats. Neurobiol. Aging. 3:1982;23-29.
16. Porsolt R.D., Martin P., Fromage S., Lenègre A., Drieu K. Anti-stress effects of EGb 761 in rodents models. In: Y. Christen et al. (Eds.), Effects of Ginkgo biloba extract (EGb 761) on the central nervous system, Elsevier, Paris. Advances in Ginkgo biloba Extract Research. 1:1992;135-145.
17. Porsolt R.D., Martin P., Lenègre A., Fromage S., Drieu K. Effects of an extract of Ginkgo biloba (EGb 761) on 'learned helplessness' and other models of stress in rodents. Pharmacol. Biochem. Behav. 36:1990;963-971.
18. Rapin J.R., Lamproglou I., Drieu K. Anti-stress activity of Ginkgo biloba extract on a learning test and neuroendocrine response. In: Christen, Y., et al. (eds.), Effects of Ginkgo biloba extract (EGb 761) on aging and age related disorders, Elsevier, Paris. Advances in Ginkgo biloba Extract Research. 4:1995;99-106.
19. Rapin J.R., Provost P., Drieu K. Hippocampal glucocorticoid receptor II down regulation in rats; effects of Ginkgo biloba extract (EGb 761). Eur. J. Endocrinol. 130(Suppl.2):1994;127.
20. Robak J., Gryglewski R.J. Flavonoids are scavengers of superoxyde anions. Biochem. Pharmacol. 37:1988;837-841.
21. Robinson D.S., Nies A., Davis J.N., Bunney W.E., Davis J.M., Colbutn R.W., Shaw D.M., Coppen A.J. Ageing, monoamines and monoamine-oxydases levels. Lancet. 1:1972;290-291.
22. Rodriguez de Turco E.B., Droy-Lefaix T., Bazan N.G. EGb 761 inhibits stress-induced polydipsia in rats. Physiol. Behav. 53:1993;1001-1002.
23. Sapolsky R.M. The physiological relevance of glucocorticoid endagerment of the hippocampus. Ann. NY Acad. Sci. 746:1994;294-307.
24. Sapolsky R.M. Why stress is teas for your brain. Science. 273:1996;749-750.
25. SAS Institute Inc, 1990. SAS/STAT User's Guide, Version 6, fourth edition, Vol. 2. SAS Institute Inc, Cavy, NC.
26. Saura J., Andres C., Andrade C., Ojuel J., Erikson K., Mahy N. Biphasic and region specific MAO-B response to aging in normal human brain. Neurobiol. Aging. 18:1997;497-507.
27. Shen J.C., Zhou D.Y. Efficiency of Ginkgo biloba extract (EGb 761) in antioxydant protection against myocardial ischemia and reperfusion injury. Biochem. Mol. Biol. Int. 35:1995;125-134.
28. Shih J.C. Singer T.P. et al. Monoamine Oxydase: Structure, Function and Altered Functions. 1979;413-421 Academic Press, New York.
29. Sladek J.R., Sladek C.D. Relative quantification of monoamine histofluorescence in young and old non-human primates. Adv. Exp. Med. Biol. 113:1979;231-240.
30. Sràm R.J., Binkovà B., Stejskalovà J., Topinka J. Effect of EGb 761 on lipid peroxidation, DNA repair and antioxienzyme activity. In: Ferradini, C., et al. (Eds.), Ginkgo biloba extract (EGb 761) as a free radical scavenger, Elsevier, Paris. Advances in Ginkgo biloba Extract Research. 2:1993;27-38.
31. Strolin-Benedetti M., Keane P.E. Differential changes in monoamine oxidase A and B activity in the ageing rat brain. J. Neurochem. 35:1980;1026-1032.
32. Tipton K.F., Youdim M.B.H. Essay of monoamine oxydase. Foundation C. Monoamine Oxydase and Its Inhibition. 1976;393-403 Elsevier, Amsterdam.
33. White H.L., Scates P.W., Cooper B.R. Extracts of Ginkgo biloba leaves inhibit monoamine oxydase. Life Sci. 58:1996;1315-1321.
34. Willner P., Towell A., Sampson S., Sokholeous S. Reduction of sucrose preference by chronic unpredictable mild stress and its restauration by a tricyclic antidepressant. Psychopharmacology. 93:1987;358-364.
35. Winter J.C. The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiol. Behav. 63(3):1998;425-433.
36. Wu W.R., Zhu X.Z. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci. 65:1999;157-164.